CompaniesByCap
LEXX
Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare

Lexaria Bioscience Corp. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Aug 2025Aug 2024Aug 2023Aug 2022Aug 2021Aug 2020Aug 2019Aug 2018Aug 2017Aug 2016Aug 2015Aug 2014Oct 2013Oct 2012Oct 2011Oct 2010
Operating Activities
Operating Cash Flow-10.5M-5.0M-5.9M-4.9M-4.0M-2.6M-3.0M-2.5M-1.5M-660,856-1.5M-515,817321,000135,943109,837-330,336
Depreciation & Amort.51,22542,448145,397102,718111,718
Investing Activities
Capital Expenditure24,64643,01433,74849,1920646,18303,0940
Free Cash Flow-10.5M-5.0M-5.9M-4.9M-2.6M-3.7M-1.5M-663,950-1.5M
Financing Activities
Dividends Paid
Stock Buybacks

Lexaria Bioscience Corp. Cash Flow — FAQ

Lexaria Bioscience Corp. (LEXX) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LEXX's cash flow history?

The chart and table above show Lexaria Bioscience Corp.'s cash flow by year and by quarter, including the growth rate.